Progyny (PGNY) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Progyny (PGNY) do?
Progyny Inc (PGNY) is a U.S.-listed company in Healthcare (Healthcare Plans). What it does: Manages employer-sponsored fertility and women's health benefit packages. Bundles fertility, family building, and menopause benefits into employer-sponsored plans using a specialized clinic. It is worth $2.61B on the market and sold $1.34B over the last year.
- Market cap
- $2.61B
- P/E ratio
- 32.5×
- Annual sales
- $1.34B
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Brief updated
- Nov 08, 2026
PGNY’s flags, in plain English
Each flag is a number from Progyny’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 08, 2026.
Low debt
Low debt, only 6% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Still Climbing
Sales up 30.2% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Earnings Jumping
Profits up 103.1% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.
Priced for Perfection
Priced at 32.5 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about PGNY
How big is Progyny?
Progyny’s market cap is $2.61B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.34B: what customers paid the company over the last year, before any costs.
What is PGNY’s P/E ratio?
PGNY’s P/E ratio is 32.5×. Investors pay about 32.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with PGNY?
Revenue depends heavily on a small base of large corporate clients renewing annual benefit contracts. That is one risk on Progyny’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Progyny’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. PGNY’s filings on SEC.gov. The Margin Monkey is research, not advice.
